JC
Insider
Jill Carroll
DirectorJill Carroll (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in AVLN. Across 1 priced purchase filing, the average 21-session return was -4.8% from execution and -4.8% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of AVLN (277,778 sh × $18.00, as filed), executed May 1.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-4.8%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-4.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
May 1
Filed May 1
Volume by month
Buys $5.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AVLN
AVLN
AVLN · 1 buy · 0 sells
1 filing
Recent filings
AVLNPURCHASE
Avalyn Pharma Inc.
View filing →
$5.0M277,778 sh × $18.00
Exec May 1
Filed May 1 · 6:50 PM ET